Lv42
586 积分 2022-06-06 加入
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
5小时前
已完结
Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges
5天前
已完结
A standing platform for cancer drug development using ctDNA-based evidence of recurrence
5天前
已完结
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
5天前
已完结
Drug-tolerant persister cells in cancer: the cutting edges and future directions
5天前
已完结
BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer
8天前
已完结
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
13天前
已完结
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
13天前
已完结
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?
15天前
已完结
Genomic Scar Score: A robust model predicting homologous recombination deficiency based on genomic instability
16天前
已完结
皖公网安备34019202002308
